celecoxib has been researched along with Neoplasms, Bone Marrow in 1 studies
Excerpt | Relevance | Reference |
---|---|---|
"Herein we analyzed the effect of cyclooxygenase-2 (COX-2) inhibitor celecoxib in a model of generalized BM dissemination of left cardiac ventricle-injected B16 melanoma (B16M) cells into healthy and bacterial endotoxin lipopolysaccharide (LPS)-pretreated mice to induce inflammation." | 3.77 | Vascular endothelial growth factor regulates melanoma cell adhesion and growth in the bone marrow microenvironment via tumor cyclooxygenase-2. ( Carrascal, T; Crende, O; Hernández, JJ; Mendoza, L; Salado, C; Valcárcel, M; Vidal-Vanaclocha, F, 2011) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Valcárcel, M | 1 |
Mendoza, L | 1 |
Hernández, JJ | 1 |
Carrascal, T | 1 |
Salado, C | 1 |
Crende, O | 1 |
Vidal-Vanaclocha, F | 1 |
1 other study available for celecoxib and Neoplasms, Bone Marrow
Article | Year |
---|---|
Vascular endothelial growth factor regulates melanoma cell adhesion and growth in the bone marrow microenvironment via tumor cyclooxygenase-2.
Topics: Animals; Blotting, Western; Bone Marrow; Bone Marrow Neoplasms; Celecoxib; Cell Adhesion; Cell Line, | 2011 |